Cargando…
Recent Advances on Drug-Loaded Mesenchymal Stem Cells With Anti-neoplastic Agents for Targeted Treatment of Cancer
Mesenchymal stem cells (MSCs), as an undifferentiated group of adult multipotent cells, have remarkable antitumor features that bring them up as a novel choice to treat cancers. MSCs are capable of altering the behavior of cells in the tumor microenvironment, inducing an anti-inflammatory effect in...
Autores principales: | Babajani, Amirhesam, Soltani, Pegah, Jamshidi, Elham, Farjoo, Mohammad Hadi, Niknejad, Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390947/ https://www.ncbi.nlm.nih.gov/pubmed/32793565 http://dx.doi.org/10.3389/fbioe.2020.00748 |
Ejemplares similares
-
Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs
por: Jamshidi, Elham, et al.
Publicado: (2021) -
Angiogenesis and Re-endothelialization in decellularized scaffolds: Recent advances and current challenges in tissue engineering
por: Mazloomnejad, Radman, et al.
Publicado: (2023) -
Anti-cancer effects of human placenta-derived amniotic epithelial stem cells loaded with paclitaxel on cancer cells
por: Babajani, Amirhesam, et al.
Publicado: (2022) -
Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammation
por: Babajani, Amirhesam, et al.
Publicado: (2022) -
Targeted Mitochondrial Therapy With Over-Expressed MAVS Protein From Mesenchymal Stem Cells: A New Therapeutic Approach for COVID-19
por: Babajani, Amirhesam, et al.
Publicado: (2021)